Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Rebecca Lynn Kelso, MD, is a vascular surgeon in the Department of Vascular Surgery of the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. She specializes in the treatment of peripheral vascular disease, including endovascular therapy and urgent surgery.
A native of Charlotte, NC, Dr. Kelso earned her medical degree at the University of North Carolina School of Medicine, Chapel Hill. She served her internship and residency in general surgery at the University of Southern California + Los Angeles County (USC+LAC) Hospitals. Following completion of her training in 2006, Dr. Kelso was named Attending Surgeon and Unit Chief with the medical center’s Emergency Surgery Service and Minimally Invasive Surgery Program. She also was an Assistant Professor of Clinical Surgery at the University of Southern California from 2006 through 2007.
While at the USC + LAC Hospitals, Dr. Kelso developed an interest in vascular surgery, and in 2007 came to Cleveland Clinic for advanced subspecialty training as a Clinical Fellow in Vascular Surgery. She completed her fellowship in 2009.
Dr. Kelso has co-authored papers published in leading medical journals and has presented at several highly respected surgical society meetings, including the Association of Women Surgeons Annual Meeting. She is a member of the American College of Surgeons, among other professional organizations, and is a candidate for membership to the Society of Vascular Surgeons.
Dr. Kelso combines her subspecialty interest with a commitment to mentoring young surgeons, serving on the Society for Vascular Surgery Young Surgeons Advisory Committee and the Cleveland Clinic Surgical Education Committee. She is board-certified in surgery and vascular surgery.
Aortic aneurysm surgery, carotid artery endarterectomy and stenting, mesenteric artery occlusive and aneurysmal disease, surgery for peripheral arterial disease, surgery for thoracic outlet syndrome, dialysis access surgery, chronic venous occlusion treatment
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/29/2015, Dr. Kelso has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.